| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen fails
|
Hu, Weiheng
|
|
2014
|
73 |
6 |
p. 1129-1136
|
artikel
|
| 2 |
An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
|
Darwish, Mona
|
|
2014
|
73 |
6 |
p. 1119-1127
|
artikel
|
| 3 |
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
|
Saloura, Vassiliki
|
|
2014
|
73 |
6 |
p. 1227-1239
|
artikel
|
| 4 |
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
|
Saloura, Vassiliki
|
|
|
73 |
6 |
p. 1227-1239
|
artikel
|
| 5 |
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
|
Maison-Blanche, Pierre
|
|
2014
|
73 |
6 |
p. 1241-1252
|
artikel
|
| 6 |
A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
|
Wang, Yan
|
|
2014
|
73 |
6 |
p. 1155-1161
|
artikel
|
| 7 |
Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers
|
Shumaker, Robert C.
|
|
2014
|
73 |
6 |
p. 1109-1117
|
artikel
|
| 8 |
Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells
|
Roy, Sudipa S.
|
|
2014
|
73 |
6 |
p. 1263-1271
|
artikel
|
| 9 |
Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy
|
Mwinyi, Jessica
|
|
2014
|
73 |
6 |
p. 1181-1188
|
artikel
|
| 10 |
Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients
|
Slusarz, Katherine M.
|
|
2014
|
73 |
6 |
p. 1197-1204
|
artikel
|
| 11 |
Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993)
|
Reid, Joel M.
|
|
2014
|
73 |
6 |
p. 1137-1146
|
artikel
|
| 12 |
Pharmacokinetics and exposure–effect relationships of capecitabine in elderly patients with breast or colorectal cancer
|
Daher Abdi, Z.
|
|
2014
|
73 |
6 |
p. 1285-1293
|
artikel
|
| 13 |
Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction
|
Krens, L. L.
|
|
2014
|
73 |
6 |
p. 1303-1306
|
artikel
|
| 14 |
Pharmacokinetics of pazopanib administered in combination with bevacizumab
|
Imbs, Diane-Charlotte
|
|
2014
|
73 |
6 |
p. 1189-1196
|
artikel
|
| 15 |
Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumors
|
Salazar, Ramon
|
|
2014
|
73 |
6 |
p. 1205-1215
|
artikel
|
| 16 |
Phase I and pharmacokinetic study of polymeric micelle-formulated paclitaxel in adult Chinese patients with advanced solid tumors
|
Lv, Fangfang
|
|
2014
|
73 |
6 |
p. 1173-1179
|
artikel
|
| 17 |
Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
|
Toyoda, Masanori
|
|
2014
|
73 |
6 |
p. 1295-1301
|
artikel
|
| 18 |
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma
|
García del Muro, Xavier
|
|
2014
|
73 |
6 |
p. 1095-1107
|
artikel
|
| 19 |
Safety analysis of two different regimens of uracil–tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial
|
Tsuchiya, Takashi
|
|
2014
|
73 |
6 |
p. 1253-1261
|
artikel
|
| 20 |
Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease
|
Choi, Moon Ki
|
|
2014
|
73 |
6 |
p. 1217-1225
|
artikel
|
| 21 |
Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
|
Tas, Faruk
|
|
2014
|
73 |
6 |
p. 1163-1171
|
artikel
|
| 22 |
Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase
|
Fernandez, C. A.
|
|
2014
|
73 |
6 |
p. 1307-1313
|
artikel
|
| 23 |
The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells
|
Azijli, Kaamar
|
|
2014
|
73 |
6 |
p. 1273-1283
|
artikel
|
| 24 |
Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy
|
Taguchi, Takahide
|
|
2014
|
73 |
6 |
p. 1147-1154
|
artikel
|
Tijdschrift beschrijving